Streetbeat News

Earnings

SONO

Sonos reported better-than-expected Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:18 pm

LTRN

Lantern Pharma reported Q2 losses of $0.44 per share, missing the analyst consensus estimate of $0.43 by 2.33%. This represents a 7.32% increase in losses compared to the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 09, 2023 | 8:18 pm

MYO

Myomo reported Q2 earnings per share (EPS) of $(0.04), missing the analyst consensus estimate of $(0.03) by 33.33%. However, the company's quarterly sales of $5.96M beat the estimate of $5.63M by 5.84%. Compared to the same period last year, the EPS increased by 90.48% and sales increased by 62.02%.

Portfolio Pulse from saritha@benzinga.com

August 09, 2023 | 8:18 pm

JSDA

Jones Soda (OTC:JSDA) reported Q2 losses of $(0.01) per share, a 50% improvement from $(0.02) per share YoY. However, sales decreased by 20.10% to $4.81 million from $6.01 million YoY.

Portfolio Pulse from totan@benzinga.com

August 09, 2023 | 8:18 pm

CARG

CarGurus reported better-than-expected Q2 financial results and issued Q3 adjusted EPS guidance above estimates, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:18 pm

AVPT

AvePoint (NASDAQ:AVPT) reported Q2 losses of $(0.07) per share, missing the analyst consensus estimate of $0.01 by 800 percent. This is a 40 percent decrease over losses from the same period last year. However, the company reported quarterly sales of $64.87 million, beating the analyst consensus estimate of $61.78 million by 5.00 percent, a 16.46 percent increase over sales from the same period last year.

Portfolio Pulse from vinayak@benzinga.com

August 09, 2023 | 8:17 pm

NDLS

Noodles (NASDAQ:NDLS) reported Q2 losses of $(0.02) per share, missing the analyst consensus estimate of $0.05 by 140%. The company also reported quarterly sales of $125.15 million, missing the analyst consensus estimate of $136.40 million by 8.24%. This represents a decrease in earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:17 pm

FOSL

Fossil Group has revised its worldwide net sales forecast, now expecting a decrease of 5-10% compared to the previous guidance of a decrease of 5% to an increase of 1%.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:17 pm

JAZZ

Jazz Pharmaceuticals reported Q2 earnings of $4.51 per share, beating the analyst consensus estimate of $4.43 by 1.81%. This is a 4.88% increase from the same period last year. The company also reported quarterly sales of $957.32 million, beating the analyst consensus estimate of $942.86 million by 1.53%. This is a 2.62% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 8:17 pm

MTNB

Matinas BioPharma Hldgs (AMEX:MTNB) reported Q2 losses of $(0.03) per share, which is in line with analyst consensus estimates and unchanged from the same period last year.

Portfolio Pulse from saritha@benzinga.com

August 09, 2023 | 8:17 pm